Detalles de la búsqueda
1.
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
Br J Cancer
; 108(4): 887-900, 2013 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23462807
2.
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
Ann Oncol
; 24(4): 1011-7, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23136231
3.
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
Cancer Metastasis Rev
; 30(1): 83-95, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21249423
4.
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.
Br J Cancer
; 107(10): 1665-71, 2012 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23132391
5.
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.
Gynecol Oncol
; 123(1): 37-42, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21764430
6.
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer.
Eur J Cancer
; 47(11): 1660-8, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21549588
Resultados
1 -
6
de 6
1
Próxima >
>>